Your browser doesn't support javascript.
loading
Functional screening of selective mitochondrial inhibitors of Plasmodium.
Gomez-Lorenzo, Maria G; Rodríguez-Alejandre, Ane; Moliner-Cubel, Sonia; Martínez-Hoyos, María; Bahamontes-Rosa, Noemí; Gonzalez Del Rio, Rubén; Ródenas, Carolina; Fuente, Jesús de la; Lavandera, Jose Luis; García-Bustos, Jose F; Mendoza-Losana, Alfonso.
Afiliação
  • Gomez-Lorenzo MG; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Rodríguez-Alejandre A; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Moliner-Cubel S; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Martínez-Hoyos M; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Bahamontes-Rosa N; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Gonzalez Del Rio R; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain.
  • Ródenas C; Centro de Investigación Básica (CIB) GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Fuente J; Centro de Investigación Básica (CIB) GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Lavandera JL; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain; Department of Basic Medical Science, CEU San Pablo University, Julián Romea 23, 28003, Madrid, Spain.
  • García-Bustos JF; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain; Department of Microbiology and Biomedicine Discovery Institute, Monash University, 3800, VIC, Australia.
  • Mendoza-Losana A; Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain. Electronic address: alfonso.x.mendoza@gsk.com.
Int J Parasitol Drugs Drug Resist ; 8(2): 295-303, 2018 08.
Article em En | MEDLINE | ID: mdl-29775797

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Avaliação Pré-Clínica de Medicamentos / Mitocôndrias / Antimaláricos Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Avaliação Pré-Clínica de Medicamentos / Mitocôndrias / Antimaláricos Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha